Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €118.41 EUR
Change Today +2.76 / 2.38%
Volume 1.8M
BAYN On Other Exchanges
Symbol
Exchange
OTC US
Xetra
OTC US
BrsaItaliana
Xetra
Mexico
Continuous
As of 1:20 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas de Win

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

57€247,000

Background*

Mr. Thomas de Win serves as the Commercial Clerk at Bayer AG (Formerly, Bayer Aktiengesellschaft). Mr. de Win joined Bayer AG in 1974. From 1976 to 1984, he held various positions in the Central Representative Body for Young Workers and Trainees. He served as a Vice Chairman of Supervisory Board at Bayer AG since March 2, 2006. He served as a Deputy Chairman of Supervisory Board at Bayer Schering Pharma AG since March 2006. He served s a Member of the Supervisory Board ...

Read Full Background

Corporate Headquarters*

Kaiser-Wilhelm-Allee 1
Leverkusen, North Rhine-Westphalia 51368

Germany

Phone: 49 214 301
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation€247,000
Total Calculated Compensation€247,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAYN:GR €118.41 EUR +2.76

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
$500.0K
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
Olivier Brandicourt Chief Executive Officer and Director
Sanofi
--
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAYER AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.